Cas 866002-10-0,4-[4-(5-Trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-benzoic acid tert-butyl ester

866002-10-0

Post Buying Request

Basic information

Product Name: 4-[4-(5-Trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-benzoic acid tert-butyl ester
Synonyms: 4-[4-(5-Trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-benzoic acid tert-butyl ester
CAS NO:866002-10-0
Molecular Formula:
Molecular Weight: 407.436
EINECS: N/A
Product Categories: N/A
Mol File: 866002-10-0.mol
Article Data: 1

Chemical Properties

Melting Point: N/A
Boiling Point: N/A
Flash Point: N/A
Appearance: N/A
Density: N/A
Refractive Index: N/A
Storage Temp.: N/A
Solubility: N/A
CAS DataBase Reference: 4-[4-(5-Trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-benzoic acid tert-butyl ester(CAS DataBase Reference)
NIST Chemistry Reference: 4-[4-(5-Trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-benzoic acid tert-butyl ester(866002-10-0)
EPA Substance Registry System: 4-[4-(5-Trifluoromethyl-pyridin-2-yl)-piperazin-1-yl]-benzoic acid tert-butyl ester(866002-10-0)

Safety Data

Hazard Codes: N/A
Statements: N/A
Safety Statements: N/A
WGK Germany:
RTECS:
HazardClass: N/A
PackingGroup: N/A
Hazardous Substances Data: 866002-10-0(Hazardous Substances Data)

Suppliers
Usage
Upstream product
Downstream Products
Article

866002-10-0 Suppliers

Recommended suppliersmore

866002-10-0 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 866002-10-0 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 8,6,6,0,0 and 2 respectively; the second part has 2 digits, 1 and 0 respectively.
Calculate Digit Verification of CAS Registry Number 866002-10:
(8*8)+(7*6)+(6*6)+(5*0)+(4*0)+(3*2)+(2*1)+(1*0)=150
150 % 10 = 0
So 866002-10-0 is a valid CAS Registry Number.

866002-10-0Upstream product

866002-10-0Downstream Products

866002-10-0Relevant articles and documents

INHIBITORS OF HISTONE DEACETYLASE

-

Page/Page column 146-147, (2010/02/14)

The invention relates to a series of compounds useful for inhibiting histone deacetylase (HDAC) enzymatic activity. The invention also provides a method for inhibiting histone descetylase in a cell using said compounds as well as a method for treating cell proliferative diseases and conditions using said HDAC inhibitors. Further, the invention provides pharmaceutical compositions comprising the HDAC inhibiting compounds and a pharmaceutically acceptable carrier.

Post a RFQ

Cas No.:

Product Name:

Quantity:

Email:

Company name:

Valid Period:

Detailed Requirements:

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

What can I do for you?
Get Best Price

Get Best Price for 866002-10-0